Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 290

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 290
---
 19.99% cap of 7,180,504shares (the “Exchange Cap”) unless stockholder approval is obtained. The Company intends to seek such approval at its annual meeting scheduled for December 19, 2025.

In connection with the SEPA, Yorkville agreed to provide up to $ 6.0million of pre-paid advances via convertible promissory notes. On October 27, 2025, the Company received $ 3,720,000and issued a $ 4.0million note ( 7% original issue discount, “OID”). A second $ 1,860,000tranche is expected upon registration effectiveness and receipt of stockholder approval, against a $ 2.0million note ( 7% OID). The notes bear interest at 8% (increasing to 18% upon default), mature on October 24, 2026, and are convertible at $ 1.50per share, subject to proportional anti-dilution and price-protection adjustments (not below a contractual floor). Beginning January 7, 2026, and monthly thereafter, the Company must repay one-tenth (1/10) of the then-outstanding principal plus accrued interest (a 5% premium applies to cash repayments).Installments may be satisfied via SEPA advances without the premium, and SEPA proceeds must be applied first to repay the notes until they are repaid in full.

The Company paid a $ 25,000structuring fee and issued 131,909commitment shares with an aggregate value of $ 200,000. It also engaged Revere Securities LLC as finder, for which it will pay a cash fee equal to 8% of pre-paid advances and $ 18,000per month for 12 months, with the aggregate monthly fees payable upon the Company raising at least $ 5.0million in additional financing. While the notes are outstanding, the Company is prohibited from third-party variable-rate transactions, and Yorkville has agreed to no short sales.

The funded note will be recorded net of OID and finder’s fees as a debt discount amortized to interest. All embedded features are being evaluated under ASC 815. The commitment shares and structuring fee are expected to be deferred offering costs of future SEPA issuances. As of the date of this filing, the Company had received $ 3.72million, issued the $ 4.0million note, and no SEPA share sales occurred.

| F-44 |

<div